• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WILLIAM COOK EUROPE ZENITH ALPHA¿ THORACIC ENDOVASCULAR GRAFT DISTAL EXTENSIONS; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WILLIAM COOK EUROPE ZENITH ALPHA¿ THORACIC ENDOVASCULAR GRAFT DISTAL EXTENSIONS; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number ZTA-DE-38-91-W1
Device Problems Off-Label Use (1494); Failure to Advance (2524)
Event Date 09/13/2023
Event Type  malfunction  
Event Description
Description of event according to initial reporter: this case was within anatomical indications.Zta-pt-36-32-209-w1 (e4179753) was deployed in the arch aorta.Since type 1a endoleak was admitted, the user attempted to add zta-de-38-91-w1 (e4338064), however it could not pass through zta-pt.In the end, no additional treatment was performed, and the patient was to be observed.
 
Manufacturer Narrative
Manufacturer ref# (b)(4).Blank fields on this form indicate the information is unknown or unavailable.Received by manufacturer 13sep2023 and assessed not reportable however investigation findings change assessment to reportable 07dec2023 g4) similar to device under pma/510(k) p140016 summary of investigational findings: a patient underwent thoracic endovascular aortic repair (tevar) to treat aortic aneurysm.A zta-pt-36-32-209-w1 was implanted in the aortic arch just distal to the brachiocephalic trunk (related complaint).It is reported that the patient had tortuous anatomy but was still inside patient selection criteria in the instruction for use.After deployment of zta-pt-36-32-209-w1 a type 1a endoleak was detected.The user then attempted to add a distal extension zta-de-38-91-w1 (complaint device) proximal to the already deployed stent graft to resolve the endoleak.It was however not possible to advance the distal extension through the proximal stent graft.The procedure ended with no additional treatment performed, and the patient was to be observed.Zta-de-38-91-w1 (complaint device) has been returned and device evaluation has been performed.The dilator tip and the tip of the sheath was inspected and no nonconformances were found.No indentations or damages were observed on the sheath or other parts of the device.It was not possible to establish the cause of inability to advance the device through the zta-pt based on the device evaluation.Review of the device history record found that all discovered non-conformances were properly dispositioned before release and no indication that the device was produced outside of specification.The instruction for use states "additional proximal main body components may be used to extend graft coverage proximally.Distal extensions are used to extend the distal body of an in situ endovascular graft" and "the zenith alpha thoracic endovascular graft is indicated for the endovascular treatment of patients with aneurysms or ulcers of the descending thoracic aorta".In this case the intention was to insert a distal extension (complaint device) in the aortic arch, proximal to an already inserted stent graft thus the use of complaint device is considered outside the ifu.Upon review of provided information it¿s not possible to determine an exact cause for the issues regarding advancement of complaint device.It cannot be ruled out that the intended placement of the complaint device in the aortic arch and the reported tortuous anatomy has made advancement through the zta-pt difficult.Cook medical will continue to monitor for similar events.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZENITH ALPHA¿ THORACIC ENDOVASCULAR GRAFT DISTAL EXTENSIONS
Type of Device
MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
WILLIAM COOK EUROPE
sandet 6
bjaeverskov 4632
DA  4632
Manufacturer (Section G)
WILLIAM COOK EUROPE
sandet 6
bjaeverskov 4632
DA   4632
Manufacturer Contact
henriette s. christiansen
sandet 6
bjaeverskov 4632
DA   4632
56868686
MDR Report Key18324288
MDR Text Key330480374
Report Number3002808486-2023-00299
Device Sequence Number1
Product Code MIH
UDI-Device Identifier10827002449227
UDI-Public(01)10827002449227(17)251205(10)E4338064
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberZTA-DE-38-91-W1
Device Lot NumberE4338064
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/03/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/13/2023
Initial Date FDA Received12/14/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/05/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-